Mobia Medical (NASDAQ:MOBI) Rating Increased to Hold at Zacks Research

Mobia Medical (NASDAQ:MOBI) was upgraded by stock analysts at Zacks Research to a “hold” rating in a research report issued on Wednesday,Zacks.com reports.

A number of other equities research analysts have also commented on the company. JPMorgan Chase & Co. assumed coverage on Mobia Medical in a research report on Tuesday. They issued an “overweight” rating and a $15.00 price target for the company. Wall Street Zen raised Mobia Medical to a “hold” rating in a research report on Saturday, May 16th. Wolfe Research assumed coverage on Mobia Medical in a research report on Tuesday. They issued an “outperform” rating for the company. BTIG Research assumed coverage on Mobia Medical in a research report on Tuesday. They issued a “buy” rating and a $19.00 price target for the company. Finally, Bank of America assumed coverage on Mobia Medical in a research report on Tuesday. They issued a “buy” rating and a $16.00 price target for the company. Five research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Mobia Medical currently has a consensus rating of “Moderate Buy” and an average price target of $20.25.

Mobia Medical Trading Up 0.8%

Shares of NASDAQ:MOBI opened at $13.84 on Wednesday. Mobia Medical has a twelve month low of $10.19 and a twelve month high of $14.77. The company has a market cap of $457.90 million, a PE ratio of 66.00 and a beta of 2.84.

Mobia Medical (NASDAQ:MOBI) last issued its earnings results on Thursday, June 4th. The company reported $999.00 earnings per share for the quarter.

Insider Buying and Selling at Mobia Medical

In related news, Director William T. Harrington acquired 533,333 shares of the company’s stock in a transaction that occurred on Monday, May 11th. The shares were acquired at an average price of $15.00 per share, with a total value of $7,999,995.00. Following the acquisition, the director owned 2,006,716 shares of the company’s stock, valued at approximately $30,100,740. This trade represents a 36.20% increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Chase C. Leavitt acquired 3,000 shares of the company’s stock in a transaction that occurred on Monday, May 11th. The shares were bought at an average cost of $15.00 per share, for a total transaction of $45,000.00. Following the acquisition, the insider directly owned 3,000 shares in the company, valued at $45,000. This represents a ∞ increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have bought a total of 1,268,332 shares of company stock worth $19,024,980 in the last three months.